Joyce B. Reome

1.4k total citations
18 papers, 1.1k citations indexed

About

Joyce B. Reome is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Joyce B. Reome has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 5 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Joyce B. Reome's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (12 papers). Joyce B. Reome is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (12 papers). Joyce B. Reome collaborates with scholars based in United States. Joyce B. Reome's co-authors include Richard Dutton, Mark J. Dobrzanski, Susan L. Swain, Hiromasa Hamada, Sara Misra, María de la Luz García-Hernández, Tara M. Strutt, Joseph A. Hollenbaugh, Andrea M. Cooper and K. Kai McKinstry and has published in prestigious journals such as The Journal of Immunology, Cancer Research and The FASEB Journal.

In The Last Decade

Joyce B. Reome

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce B. Reome United States 14 937 337 212 115 55 18 1.1k
Javier Vega‐Ramos Australia 15 1.3k 1.4× 276 0.8× 150 0.7× 200 1.7× 52 0.9× 19 1.5k
Vasileios Bekiaris Denmark 20 897 1.0× 214 0.6× 129 0.6× 146 1.3× 61 1.1× 36 1.2k
Caroline Dubey United States 13 1.1k 1.2× 187 0.6× 123 0.6× 163 1.4× 55 1.0× 15 1.3k
Naoto Matsuki United States 9 1.7k 1.8× 362 1.1× 189 0.9× 147 1.3× 81 1.5× 15 1.9k
S K Narula United States 14 671 0.7× 288 0.9× 107 0.5× 215 1.9× 113 2.1× 24 983
Anthony E. Zamora United States 15 607 0.6× 381 1.1× 127 0.6× 215 1.9× 67 1.2× 33 952
Justin R Killebrew United States 4 958 1.0× 176 0.5× 79 0.4× 125 1.1× 65 1.2× 6 1.1k
Stefanie Willenzon Germany 10 617 0.7× 237 0.7× 96 0.5× 104 0.9× 33 0.6× 17 843
Hongwei H. Zhang United States 12 709 0.8× 218 0.6× 86 0.4× 126 1.1× 25 0.5× 18 917
Noriko Morishima Japan 13 926 1.0× 452 1.3× 103 0.5× 140 1.2× 57 1.0× 23 1.2k

Countries citing papers authored by Joyce B. Reome

Since Specialization
Citations

This map shows the geographic impact of Joyce B. Reome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce B. Reome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce B. Reome more than expected).

Fields of papers citing papers by Joyce B. Reome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce B. Reome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce B. Reome. The network helps show where Joyce B. Reome may publish in the future.

Co-authorship network of co-authors of Joyce B. Reome

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce B. Reome. A scholar is included among the top collaborators of Joyce B. Reome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce B. Reome. Joyce B. Reome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
García-Hernández, María de la Luz, Hiromasa Hamada, Joyce B. Reome, et al.. (2010). Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice. The Journal of Immunology. 184(8). 4215–4227. 89 indexed citations
2.
Hamada, Hiromasa, María de la Luz García-Hernández, Joyce B. Reome, et al.. (2009). Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge. The Journal of Immunology. 182(6). 3469–3481. 286 indexed citations
3.
Hamada, Hiromasa, María de la Luz García-Hernández, Joyce B. Reome, Sara Misra, & Richard Dutton. (2009). The mechanism of protection against influenza by transfer of Tc17, an IL-17 secreting CD8 T cell subset. (46.5). The Journal of Immunology. 182(1_Supplement). 46.5–46.5. 1 indexed citations
4.
5.
6.
Hamada, Hiromasa, Joyce B. Reome, Sara Misra, et al.. (2008). Tc17, a new subset of CD8 T cells. The FASEB Journal. 22(S2). 358–358. 1 indexed citations
7.
Powell, Timothy J., Tara M. Strutt, Joyce B. Reome, et al.. (2007). Priming with Cold-Adapted Influenza A Does Not Prevent Infection but Elicits Long-Lived Protection against Supralethal Challenge with Heterosubtypic Virus. The Journal of Immunology. 178(2). 1030–1038. 116 indexed citations
8.
9.
Dobrzanski, Mark J., Joyce B. Reome, Joseph A. Hollenbaugh, & Richard Dutton. (2004). Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses. The Journal of Immunology. 172(3). 1380–1390. 55 indexed citations
10.
Hollenbaugh, Joseph A., Joyce B. Reome, Mark J. Dobrzanski, & Richard Dutton. (2004). The Rate of the CD8-Dependent Initial Reduction in Tumor Volume Is Not Limited by Contact-Dependent Perforin, Fas Ligand, or TNF-Mediated Cytolysis. The Journal of Immunology. 173(3). 1738–1743. 38 indexed citations
11.
Reome, Joyce B., et al.. (2004). Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Clinical Immunology. 111(1). 69–81. 46 indexed citations
12.
13.
Dobrzanski, Mark J., Joyce B. Reome, & Richard Dutton. (2001). Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection. The Journal of Immunology. 167(1). 424–434. 41 indexed citations
14.
Dobrzanski, Mark J., Joyce B. Reome, & Richard Dutton. (2001). Immunopotentiating Role of IFN-γ in Early and Late Stages of Type 1 CD8 Effector Cell-Mediated Tumor Rejection. Clinical Immunology. 98(1). 70–84. 44 indexed citations
15.
Reome, Joyce B., et al.. (2000). The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System. The Journal of Immunology. 165(8). 4226–4230. 25 indexed citations
16.
Dobrzanski, Mark J., Joyce B. Reome, & Richard Dutton. (2000). Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor. The Journal of Immunology. 164(2). 916–925. 67 indexed citations
17.
Dobrzanski, Mark J., Joyce B. Reome, & Richard Dutton. (1999). Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases. The Journal of Immunology. 162(11). 6671–6680. 99 indexed citations
18.
Cerwenka, Adelheid, Laura Carter, Joyce B. Reome, Susan L. Swain, & Richard Dutton. (1998). In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines. The Journal of Immunology. 161(1). 97–105. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier Vega‐Ramos Breakdown of academic impact, for papers by Vasileios Bekiaris Breakdown of academic impact, for papers by Caroline Dubey Breakdown of academic impact, for papers by Naoto Matsuki Breakdown of academic impact, for papers by S K Narula Breakdown of academic impact, for papers by Anthony E. Zamora Breakdown of academic impact, for papers by Justin R Killebrew Breakdown of academic impact, for papers by Stefanie Willenzon Breakdown of academic impact, for papers by Hongwei H. Zhang Breakdown of academic impact, for papers by Noriko Morishima
Rankless by CCL
2026